International Journal of Rheumatology最新文献

筛选
英文 中文
Rheumatic Heart Disease in East Africa: A Systematic Review and Meta-Analysis. 东非风湿性心脏病:系统综述和荟萃分析。
IF 2.3
International Journal of Rheumatology Pub Date : 2023-09-19 eCollection Date: 2023-01-01 DOI: 10.1155/2023/8834443
Guesh Mebrahtom, Abrha Hailay, Woldu Aberhe, Kidane Zereabruk, Teklehaimanot Haile
{"title":"Rheumatic Heart Disease in East Africa: A Systematic Review and Meta-Analysis.","authors":"Guesh Mebrahtom,&nbsp;Abrha Hailay,&nbsp;Woldu Aberhe,&nbsp;Kidane Zereabruk,&nbsp;Teklehaimanot Haile","doi":"10.1155/2023/8834443","DOIUrl":"https://doi.org/10.1155/2023/8834443","url":null,"abstract":"<p><strong>Background: </strong>Despite being a grave problem, there is little information on rheumatic heart disease's prevalence in East Africa. Therefore, the purpose of this systematic review and meta-analysis was to estimate the pooled prevalence of rheumatic heart disease in East Africa.</p><p><strong>Materials and methods: </strong>A computerized systematic search of using multiple database searching engines was performed in search of relevant English articles from the inception of the databases to December 2019. It was done in accordance with the preferred reporting items for systematic review and meta-analysis (PRISMA) standard. The funnel plot was used to assess publication bias. R and RStudio for Windows were used for all statistical analysis. The random-effect model was used for calculating the pooled estimate of the prevalence of rheumatic heart disease.</p><p><strong>Results: </strong>The database search retrieved 1073 papers, and 80 articles (78 cross-sectional and two cohort study designs) with a total of 184575 individuals were found to be appropriate for the review. In East Africa, the overall prevalence of rheumatic heart disease was 14.67% (95% CI: 13.99% to 15.35%). In Ethiopia, Uganda, Tanzania, and Sudan, respectively, the subgroup analysis of rheumatic heart disease pooled prevalence was 22% (95% CI: 13% to 36%), 11% (95%t CI: 5% to 20%), 9% (95%t CI: 5% to 16%), and 3% (95%t CI: 1% to 10%), while the pooled prevalence of rheumatic heart disease in adults was 20% (95% CI: 12% to 30%), and in children, it was 4% (95% CI: 2% to 8%).</p><p><strong>Conclusions: </strong>From this report, the prevalence of rheumatic heart disease in East Africa is very high, affecting about one in seven people. Therefore, future strategies should emphasize preventive measures at appropriate times to minimize the burden of this type of preventable heart disease.</p>","PeriodicalId":51715,"journal":{"name":"International Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41158136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Primary Anti-Phospholipid Antibody Syndrome: Real-World Defining Features of Rethrombosis in the Course of Disease. 原发性抗磷脂抗体综合征:疾病过程中血栓形成的真实世界定义特征。
IF 2.3
International Journal of Rheumatology Pub Date : 2022-11-10 eCollection Date: 2022-01-01 DOI: 10.1155/2022/7331586
Maria Francisca Moraes-Fontes, Filipa Pedro, Maria Manuel Campos, Melissa Fernandes, Sule Yavuz, Francisco Oliveira, António Panarra
{"title":"Primary Anti-Phospholipid Antibody Syndrome: Real-World Defining Features of Rethrombosis in the Course of Disease.","authors":"Maria Francisca Moraes-Fontes,&nbsp;Filipa Pedro,&nbsp;Maria Manuel Campos,&nbsp;Melissa Fernandes,&nbsp;Sule Yavuz,&nbsp;Francisco Oliveira,&nbsp;António Panarra","doi":"10.1155/2022/7331586","DOIUrl":"https://doi.org/10.1155/2022/7331586","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to identify features that allow differentiation of primary antiphospholipid syndrome (PAPS) patients that suffer recurrent thrombotic events (RTE) despite anticoagulation, from the other diagnosed PAPS patients.</p><p><strong>Methods: </strong>This was an exploratory study of anticoagulated PAPS patients attending an Autoimmune Diseases Unit (1998-2018). From 2016, anti-phospholipid antibodies and lupus anticoagulant were determined for each patient at consecutive visits, collected together with retrospective clinical characteristics, laboratory, and therapeutic markers and compared according to the occurrence of thrombotic events during follow-up.</p><p><strong>Results: </strong>Overall, two thirds of the patients were female, 93% were Caucasian, with a median age of 40 years at diagnosis, for a median time of 11.5 years in follow-up. Out of 54 patients, 10 were identified with RTE. There were no significant differences among the RTE and non-RTE patients as far as classical risk factors for clotting disorders. The RTE group was characterized by a higher proportion of younger patients, male sex and positivity for all laboratory markers, and initially and over follow-up as well as a sustained high-risk profile based on APS laboratory markers. Anticardiolipin IgG at onset was the only statistically significant marker of the RTE group. At the end of follow-up, consistent reversion to negative status was a rare event, observed in 20% of RTE vs. 25% of non-RTE patients.</p><p><strong>Conclusions: </strong>Despite therapy, we were able to identify features associated to thrombotic events in patients with PAPS. Prospectively regular clinical and laboratory monitoring might be warranted in order to treat APS more assertively.</p>","PeriodicalId":51715,"journal":{"name":"International Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2022-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40698192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Knowledge and Attitude towards Osteoporosis among Syrian Women: A Cross-Sectional Study. 评估叙利亚妇女对骨质疏松症的知识和态度:一项横断面研究。
IF 2.3
International Journal of Rheumatology Pub Date : 2022-11-08 eCollection Date: 2022-01-01 DOI: 10.1155/2022/6431151
Ahmad Alhouri, Hanaa Zahrawi, Saja Alasaad, Shahd Mofid Alhayek, Hasan Nabil Al Houri, Sami Jomaa, André Torbey, Sarya Swed, Douaa Alamash, Aous Zawda, Shahad Alhattab Alhasan, Naram Khalayli, Maysoun Kudsi
{"title":"Assessing the Knowledge and Attitude towards Osteoporosis among Syrian Women: A Cross-Sectional Study.","authors":"Ahmad Alhouri,&nbsp;Hanaa Zahrawi,&nbsp;Saja Alasaad,&nbsp;Shahd Mofid Alhayek,&nbsp;Hasan Nabil Al Houri,&nbsp;Sami Jomaa,&nbsp;André Torbey,&nbsp;Sarya Swed,&nbsp;Douaa Alamash,&nbsp;Aous Zawda,&nbsp;Shahad Alhattab Alhasan,&nbsp;Naram Khalayli,&nbsp;Maysoun Kudsi","doi":"10.1155/2022/6431151","DOIUrl":"https://doi.org/10.1155/2022/6431151","url":null,"abstract":"<p><strong>Background: </strong>Osteoporosis is a progressive decline in the bone mass, which occurs with no alterations to the bone's composition. It is associated with increased bone fragility that may eventually lead to fractures. In this study, we aim to assess the level of awareness that Syrian women possess regarding osteoporosis and spread the knowledge about its prevention measures.</p><p><strong>Methods: </strong>This study was approved by the Institutional Review Board of the Syrian Private University. A validated questionnaire was asked to be filled in by women aged 18 and above, who were presented to clinics at Damascus, Al Helal, and Al Zahrawi hospitals between 28 November 2021 and 5 March 2022.</p><p><strong>Results: </strong>6082 women were included, of which 63.9% (<i>n</i> = 3884) were under 30 years old and 89.3% (<i>n</i> = 5429) were in their reproductive age. The average knowledge score of osteoporosis was 69.2 ± 7.7 (28-100); 88.1% correctly defined osteoporosis while the majority (93.4%) has heard of it. The majority of our participants were living in rural areas (77.2%; <i>n</i> = 4698) while only 22.8% (<i>n</i> = 1384) were living in urban areas. The respondents from urban areas reported the highest knowledge scores (OR = 1.472; 95% CI: 1.258-1.723; <i>P</i> < 0.0001). 75.60% agreed that aging is a risk factor for osteoporosis. 64.6% were aware that osteoporosis is directly responsible for hip fractures. Smoking, family history, lack of exercise, and menopause were the main risk factors for osteoporosis, at 53.6%, 53.1%, 84.6%, and 60.7%, respectively. Social media represented the ultimate source of information on osteoporosis (64.70%).</p><p><strong>Conclusion: </strong>Our study is the largest in the region and the first of its kind in the country. Syrian women had an average knowledge score regarding osteoporosis; the vast majority has defined it correctly and has heard of it. We found no statistical significance between age or educational level and adequate knowledge about osteoporosis.</p>","PeriodicalId":51715,"journal":{"name":"International Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2022-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40695719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Usefulness of Soluble Transferrin Receptor in the Diagnosis of Iron Deficiency Anemia in Rheumatoid Arthritis Patients in Clinical Practice. 可溶性转铁蛋白受体在类风湿关节炎缺铁性贫血诊断中的临床应用
IF 2.3
International Journal of Rheumatology Pub Date : 2022-10-12 eCollection Date: 2022-01-01 DOI: 10.1155/2022/7067262
Florian Günther, Rainer H Straub, Wolfgang Hartung, Martin Fleck, Boris Ehrenstein, Louisa Schminke
{"title":"Usefulness of Soluble Transferrin Receptor in the Diagnosis of Iron Deficiency Anemia in Rheumatoid Arthritis Patients in Clinical Practice.","authors":"Florian Günther,&nbsp;Rainer H Straub,&nbsp;Wolfgang Hartung,&nbsp;Martin Fleck,&nbsp;Boris Ehrenstein,&nbsp;Louisa Schminke","doi":"10.1155/2022/7067262","DOIUrl":"https://doi.org/10.1155/2022/7067262","url":null,"abstract":"<p><strong>Aim: </strong>We analyzed the added value of sTfR measurement in routine clinical practice to standard parameters (SP) of iron deficiency in the detection of iron deficiency anemia (IDA) in patients with rheumatoid arthritis (RA).</p><p><strong>Methods: </strong>Blood samples from 116 patients with RA were analyzed in a prospective study. Based on biochemical parameters, patients were classified as having IDA, anemia of chronic disease (ACD), IDA with concomitant ACD (ACD/IDA), or \"other anemia.\" Sensitivity, specificity, positive (PPV), and negative predictive values (NPV) of sTfR and SP of iron status alone and in combination were calculated for the diagnosis of IDA in general, i.e., IDA or ACD/IDA.</p><p><strong>Results: </strong>In the whole sample, with regard to the diagnosis of iron deficiency (IDA or ACD/IDA), sTfR had a higher sensitivity compared both to the combined use of SP and to the combination of SP with sTfR (80.9% versus 66.7/54.8%). Specificity, PPV and NPV did not differ substantially. When patients were stratified in groups with high (CRP levels above the median, i.e., 24.1 mg/l) and low (CRP levels less or equal to the median) inflammation, the diagnostic superiority of sTfR was restricted to patients with high inflammation. In this group, the diagnostic performance of sTfR was superior both to the combined use of SP and the combination of SP with sTfR with higher sensitivity (100% versus 52.4%) and NPV (100% versus 77.7/76.7%) and comparable specificity and PPV.</p><p><strong>Conclusion: </strong>For the detection of iron depletion (IDA or ACD/IDA) in anemic RA patients, sTfR is superior to SP of iron deficiency only in highly inflammatory states.</p>","PeriodicalId":51715,"journal":{"name":"International Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2022-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40567291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience. 评估系统性幼年特发性关节炎患者的巨噬细胞激活综合征:单中心经验。
IF 2.3
International Journal of Rheumatology Pub Date : 2022-07-27 eCollection Date: 2022-01-01 DOI: 10.1155/2022/1784529
Pia Elkjær Høeg, Mia Glerup, Birgitte Mahler, Christian Høst, Troels Herlin
{"title":"Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience.","authors":"Pia Elkjær Høeg,&nbsp;Mia Glerup,&nbsp;Birgitte Mahler,&nbsp;Christian Høst,&nbsp;Troels Herlin","doi":"10.1155/2022/1784529","DOIUrl":"https://doi.org/10.1155/2022/1784529","url":null,"abstract":"<p><strong>Objectives: </strong>Macrophage activation syndrome (MAS) is a severe complication of systemic juvenile arthritis (sJIA), and early diagnosis is critical for survival. The objective of this study was to evaluate the 2016 MAS classification criteria in a Danish sJIA cohort and to compare different sets of criteria for the early identification of MAS including the HLH-2004 diagnostic guidelines, MS score, and the ferritin/ESR ratio.</p><p><strong>Methods: </strong>Data was extracted from medical charts of 32 patients with sJIA from a single Danish paediatric rheumatology center diagnosed between January 2014 and June 2021. Patients who met the 2016 MAS classification criteria were classified as having MAS. From a receiver operating characteristic (ROC) plot, the area under the curve (AUC) was calculated for the prediction of patients with MAS according to the 2016 MAS classification criteria using either MS score or the ferritin/ESR ratio.</p><p><strong>Results: </strong>Of the cohort, eight (25%) patients were classified as having MAS according to the 2016 MAS classification criteria compared to only three (9.4%) patients fulfilling the HLH-2004 diagnostic guidelines, all of which had recurrent MAS. The ferritin/ESR ratio showed the highest sensitivity (100%) but the lowest specificity (72.2%). In comparison, the MS score had a higher specificity (90.9%) for the identification of MAS according to the 2016 classification criteria. In our cohort, the most optimal cut-off point for the ferritin/ESR ratio was ≥19.4 (sensitivity: 100%, specificity: 72.2%) and ≥ -1.5 for the MS score (sensitivity: 71.4%, specificity: 91.7%), respectively.</p><p><strong>Conclusion: </strong>The 2016 MAS classification criteria were a valuable tool in the discrimination of sJIA with and without MAS. The HLH-2004 diagnostic guidelines showed the lowest sensitivity, ferritin/ESR ratio, and the lowest specificity compared to the MS score where an acceptable high sensitivity and specificity was found.</p>","PeriodicalId":51715,"journal":{"name":"International Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2022-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40608111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Autoimmune Idiopathic Inflammatory Myopathies: Pharmacological Differences and Similarities by Type of Myositis and by Sociodemographic Variables. 自身免疫性特发性炎性肌病:肌炎类型和社会人口变量的药理学差异和相似性。
IF 2.3
International Journal of Rheumatology Pub Date : 2022-07-05 eCollection Date: 2022-01-01 DOI: 10.1155/2022/1807571
Luis Fernando Valladales-Restrepo, Ana Camila Delgado-Araujo, Brayan Stiven Aristizábal-Carmona, Lina María Saldarriaga-Rivera, Jorge Enrique Machado-Alba
{"title":"Autoimmune Idiopathic Inflammatory Myopathies: Pharmacological Differences and Similarities by Type of Myositis and by Sociodemographic Variables.","authors":"Luis Fernando Valladales-Restrepo,&nbsp;Ana Camila Delgado-Araujo,&nbsp;Brayan Stiven Aristizábal-Carmona,&nbsp;Lina María Saldarriaga-Rivera,&nbsp;Jorge Enrique Machado-Alba","doi":"10.1155/2022/1807571","DOIUrl":"https://doi.org/10.1155/2022/1807571","url":null,"abstract":"<p><strong>Objective: </strong>Autoimmune idiopathic inflammatory myopathies (IIMs) are a group of pathologies that are generally characterized by muscle weakness. Their treatment involves glucocorticoids and immunosuppressants. The aim was to identify differences and similarities in the pharmacological management of a group of patients with autoimmune IIMs according to the type of disease, sex, age group, and city of residence in Colombia from 2020 to 2021.</p><p><strong>Methods: </strong>This cross-sectional study identified medication prescription patterns for outpatient use in patients with autoimmune IIMs between 2020 and 2021 based on a population database of 8.5 million Colombians affiliated with the Colombian health system. Sociodemographic and pharmacological variables were considered.</p><p><strong>Results: </strong>A total of 671 patients with autoimmune IIMs were identified, with a median age of 57 years, and 70.9% were women. Overlap myositis was the most frequent disease (31.4%). A total of 91.5% of the patients received pharmacological treatment, mainly systemic glucocorticoids (78.5%), conventional disease-modifying antirheumatic drugs (DMARDs) (74.1%), immunosuppressants (9.1%), and biological DMARDs (3.7%). Pharmacological management predominated among patients with overlap myositis, those who lived in cities, and those affiliated with the contributory regime of the Colombian health system. Conventional DMARDs were prescribed mainly to women and to those older than 65 years.</p><p><strong>Conclusions: </strong>Patients with autoimmune IIMs are not treated homogeneously. The pattern of drug use varies according to the type of IIM, sex, age group, city, and health system regime affiliation.</p>","PeriodicalId":51715,"journal":{"name":"International Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2022-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277175/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40601251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Depression-, Pain-, and Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus 系统性红斑狼疮患者的抑郁、疼痛和健康相关生活质量
IF 2.3
International Journal of Rheumatology Pub Date : 2022-05-05 DOI: 10.1155/2022/6290736
N. Chalhoub, M. Luggen
{"title":"Depression-, Pain-, and Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus","authors":"N. Chalhoub, M. Luggen","doi":"10.1155/2022/6290736","DOIUrl":"https://doi.org/10.1155/2022/6290736","url":null,"abstract":"Objectives A significant number of patients with systemic lupus erythematosus (SLE) have depression, and many are untreated. We aim to assess the frequency of moderate to severe depression (MSD) in a multiethnic group of SLE patients with different sociodemographic backgrounds, identify modifiable factors associated with depression, and determine the impact of depression, disease activity, damage, cognitive function, and pain severity on health-related quality of life (HRQoL). Methods Ninety-nine patients with SLE were evaluated in a cross-sectional study. Sociodemographic data, Beck Depression Inventory (BDI II), SLE disease activity index (SLEDAI-2K), SLICC Damage Index (SLICC-DI), pain severity (10 cm visual analogue scale), cognitive function (Automated Neuropsychologic Assessment Metrics (ANAM)), and the physical (PCS) and mental (MCS) component scores of the Short Form Health Survey (SF-36) were recorded. Bivariate analysis identified potential associations of relevant variables with BDI II and SF-36. Regression analysis determined independent correlates with MSD, PCS, and MCS. Results Over 50% of subjects (50.5%) were African-American, 37.1% had a family income of ≤$20,000, and 31.3% had MSD. In the bivariate analysis, family income, SLEDAI-2K, cognitive function, and pain severity were associated with MSD. Using binary logistic regression, SLEDAI-2K and pain severity remained independently correlated with MSD (p = 0.004). In the multiple linear regression analysis, pain severity was the only independent correlate of PCS (p < 0.0001), while cognitive function and BDI II were the main factors associated with MCS (p = 0.020 and p < 0.0001, respectively). Conclusion Pain severity and disease activity are associated with MSD in our unique population, are potentially modifiable, and deserve further attention in the clinic. Depression and pain significantly affect HRQoL and should be aggressively managed.","PeriodicalId":51715,"journal":{"name":"International Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43037442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Polymorphism in STAT4 Increase the Risk of Systemic Lupus Erythematosus: An Updated Meta-Analysis STAT4基因多态性增加系统性红斑狼疮发病风险的最新Meta分析
IF 2.3
International Journal of Rheumatology Pub Date : 2022-04-22 DOI: 10.1155/2022/5565057
Shancui-zheng, Jinping-Zhang, Guoyuan-lu, Lei Liu, Zhiyong-deng
{"title":"Polymorphism in STAT4 Increase the Risk of Systemic Lupus Erythematosus: An Updated Meta-Analysis","authors":"Shancui-zheng, Jinping-Zhang, Guoyuan-lu, Lei Liu, Zhiyong-deng","doi":"10.1155/2022/5565057","DOIUrl":"https://doi.org/10.1155/2022/5565057","url":null,"abstract":"Previous studies have reported that STAT4 rs7574865 conferred the susceptibility to systemic lupus erythematosus (SLE). In this study, a meta-analysis (including 32 comparative studies of 11384 patients and 17609 controls) was conducted to investigate the role of STAT4 polymorphism in SLE in a comprehensive way. We found that the Asian population had the highest prevalence of the T allele than any other study population at 32.2% and that STAT4 rs7574865 polymorphism was associated with SLE in the overall population (OR = 1.579, 95%CI = 1.497-1.665, P < 0.001). In the subgroup analysis by ethnicity, STAT4 rs7574865 T allele was shown to be risk factor in SLE in Asian, European, and American origins. Our results do support STAT4 rs7574865 polymorphism as a susceptibility factor for SLE in populations of different ethnic and that its prevalence is ethnicity dependent.","PeriodicalId":51715,"journal":{"name":"International Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2022-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49584932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Retrospective Analysis of Factors Associated with Fracture in 714 Patients with Polymyalgia Rheumatica. 714例风湿性多肌痛患者骨折相关因素回顾性分析。
IF 2.3
International Journal of Rheumatology Pub Date : 2022-02-12 eCollection Date: 2022-01-01 DOI: 10.1155/2022/9409883
Rajiv Ark, Khojasta Talash, Marwan Bukhari
{"title":"Retrospective Analysis of Factors Associated with Fracture in 714 Patients with Polymyalgia Rheumatica.","authors":"Rajiv Ark,&nbsp;Khojasta Talash,&nbsp;Marwan Bukhari","doi":"10.1155/2022/9409883","DOIUrl":"https://doi.org/10.1155/2022/9409883","url":null,"abstract":"<p><strong>Introduction: </strong>Polymyalgia rheumatica (PMR) is a disease of the elderly, associated with increased fracture risk due to glucocorticosteroid (GC) treatment with the additional possible influence of chronic inflammation. Risk factors for fracture in PMR have not been extensively studied. Hip structure analysis (HSA) is a way to measure bone morphology in the hip using dual X-ray absorptiometry (DEXA). It has been used as a predictor of fracture in epidemiological settings. HSA has not been studied in PMR before.</p><p><strong>Objectives: </strong>The object of this retrospective study was to determine if fracture risk in PMR was associated with densitometry data and to determine the influence, if any, of HSA on that association.</p><p><strong>Methods: </strong>714 patients with PMR referred for a bone density estimate at a district general hospital from June 2004 to October 2010 were studied. Demographic data, GC use, alcohol consumption, smoking status, secondary osteoporosis, and fracture history were recorded. Bone mineral density (BMD), <i>Z</i> score, <i>T</i> score, body composition data, and HSA measurements were collected. These were geometric measurements taken from 2-dimensional DEXA images of the hip. Fracture was modelled as an outcome variable using logistic regression models, adjusted for age and sex. And the fit of the model was assessed by comparing the area under the curve (AUC).</p><p><strong>Results: </strong>714 patients were studied, 532 (75%) were female, and mean age was 70.5 with SD of 8.8. 703 (98%) had been treated with GCs. Lumbar and femoral BMD models were significantly associated with fracture. Right femur OR 0.062 (0.014-0.285), left femur OR 0.098 (0.023-0.412), right femoral neck 0.078 (0.014-0.43), left femoral neck 0.104 (0.022-0.492), L1 0.192 (0.066-0.56), L2 OR 0.138 (0.053-0.358), L3 0.192 (0.079-0.463), and L4 0.243 (0.108-0.544). Cross-sectional area was the only HSA parameter that was associated with fracture OR 0.988 (0.980-0.997).</p><p><strong>Conclusion: </strong>L2 association models were strongest. Prospective studies are needed to elucidate whether these factors predict future fracture. GC data were binary, not reflecting dose and duration.</p>","PeriodicalId":51715,"journal":{"name":"International Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2022-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858072/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39943384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Polymorphisms in the FCN1, FCN2, and FCN3 Genes on the Susceptibility to Develop Rheumatoid Arthritis: A Systematic Review. FCN1、FCN2和FCN3基因多态性对类风湿关节炎易感性的影响:系统综述
IF 2.3
International Journal of Rheumatology Pub Date : 2022-01-01 DOI: 10.1155/2022/1730996
Sebastián R Gil-Quiñones, Luz Gutierrez-Castañeda, Lorena Larios-Salazar, Susana Mejia-Mesa, Adriana Motta, David Tovar-Parra
{"title":"Effect of Polymorphisms in the FCN1, FCN2, and FCN3 Genes on the Susceptibility to Develop Rheumatoid Arthritis: A Systematic Review.","authors":"Sebastián R Gil-Quiñones,&nbsp;Luz Gutierrez-Castañeda,&nbsp;Lorena Larios-Salazar,&nbsp;Susana Mejia-Mesa,&nbsp;Adriana Motta,&nbsp;David Tovar-Parra","doi":"10.1155/2022/1730996","DOIUrl":"https://doi.org/10.1155/2022/1730996","url":null,"abstract":"<p><p>Genetic association studies in rheumatoid arthritis conducted in various populations have yielded heterogeneous results. The present systematic review was conducted to synthesize the results of the studies in order to establish the impact of polymorphisms in the ficolin-coding genes FCN1, FCN2, and FCN3 on the susceptibility to develop rheumatoid arthritis. A systematic literature review was performed using the following keywords \"gene (FCN1/FCN2/FCN3)\", \"Polymorphism/Genetic Variant\", and \"rheumatoid arthritis\" in different databases until January 2022. Authors assessed articles by title/abstract and then assessed by full text for data extraction. The risk of bias was assessed using the Newcastle-Ottawa scale. Data synthesis was performed qualitatively and quantitatively. A total of 1519 articles were eligible for inclusion in this review, 3 were identified as relevant for the quantitative synthesis with 670 patients and 1019 controls. For the FCN1 gene, an association was found in the dominant and recessive genetic models of the variants rs2989727 (genotype TT = OR: 0.577, 95% CI: 0.430-0.769) and rs1071583 (genotype GG = OR: 1.537, 95% CI: 1.153-2.049, <i>p</i> = 0.0032) with the development of rheumatoid arthritis as a protective or susceptibility factor. FCN2 and FCN3 genes did not show association with disease development. The FCN1 gene variants rs2989727 and rs1071583 are associated with the risk of developing rheumatoid arthritis in populations from Brazil and Belgium, but not in FCN2 and FCN3 gene variants.</p>","PeriodicalId":51715,"journal":{"name":"International Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780007/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10804012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信